Have your own idea? Try our Stock Screener
Chinese (SSE) Biotech Industry Analysis
UpdatedJun 02, 2025
DataAggregated Company Financials
Companies71
- 7D4.0%
- 3M5.6%
- 1Y1.4%
- YTD11.0%
Over the last 7 days, the Biotech industry has risen 4.0%, driven by gains in Staidson (Beijing) BioPharmaceuticals and InventisBio of 60% and 31%, respectively. Overall in the last year, the industry is flat. As for the next few years, earnings are expected to grow by 49% per annum.
Industry Valuation and Performance
Has the Chinese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 02 Jun 2025 | CN¥875.5b | CN¥113.1b | CN¥8.3b | 35.7x | 106.1x | 7.7x |
| Wed, 30 Apr 2025 | CN¥821.1b | CN¥113.4b | CN¥7.1b | 34.9x | 116x | 7.2x |
| Fri, 28 Mar 2025 | CN¥847.3b | CN¥136.2b | CN¥11.8b | 32.6x | 71.7x | 6.2x |
| Sun, 23 Feb 2025 | CN¥862.5b | CN¥136.0b | CN¥10.8b | 35x | 80.2x | 6.3x |
| Tue, 21 Jan 2025 | CN¥804.8b | CN¥136.0b | CN¥10.8b | 32.6x | 74.8x | 5.9x |
| Thu, 19 Dec 2024 | CN¥868.5b | CN¥136.0b | CN¥10.8b | 33.4x | 80.7x | 6.4x |
| Sat, 16 Nov 2024 | CN¥917.5b | CN¥141.7b | CN¥11.2b | 36.7x | 81.9x | 6.5x |
| Mon, 14 Oct 2024 | CN¥892.8b | CN¥154.1b | CN¥14.5b | 36x | 61.8x | 5.8x |
| Wed, 11 Sep 2024 | CN¥756.5b | CN¥154.2b | CN¥14.5b | 31.2x | 52x | 4.9x |
| Fri, 09 Aug 2024 | CN¥835.7b | CN¥161.2b | CN¥17.3b | 31x | 48.3x | 5.2x |
| Sun, 07 Jul 2024 | CN¥822.1b | CN¥161.1b | CN¥17.3b | 32.1x | 47.5x | 5.1x |
| Tue, 04 Jun 2024 | CN¥892.3b | CN¥161.1b | CN¥17.3b | 33x | 51.6x | 5.5x |
| Thu, 02 May 2024 | CN¥950.7b | CN¥161.5b | CN¥17.7b | 37.7x | 53.6x | 5.9x |
| Sat, 30 Mar 2024 | CN¥971.3b | CN¥162.6b | CN¥20.7b | 39.4x | 47x | 6x |
| Mon, 26 Feb 2024 | CN¥992.7b | CN¥168.6b | CN¥21.7b | 35x | 45.8x | 5.9x |
| Wed, 24 Jan 2024 | CN¥962.9b | CN¥167.9b | CN¥21.4b | 33.5x | 45x | 5.7x |
| Fri, 22 Dec 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 39.9x | 50.6x | 6.5x |
| Sun, 19 Nov 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 41.3x | 52x | 6.6x |
| Tue, 17 Oct 2023 | CN¥1.1t | CN¥170.9b | CN¥25.2b | 44.3x | 43.1x | 6.4x |
| Thu, 14 Sep 2023 | CN¥1.0t | CN¥170.7b | CN¥25.2b | 39.7x | 40.5x | 6x |
| Sat, 12 Aug 2023 | CN¥1.1t | CN¥174.5b | CN¥28.5b | 38x | 37x | 6x |
| Mon, 10 Jul 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 38.6x | 36.1x | 6x |
| Wed, 07 Jun 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 40.3x | 37.4x | 6.2x |
| Fri, 05 May 2023 | CN¥1.2t | CN¥181.7b | CN¥31.6b | 44.4x | 38.4x | 6.7x |
| Sun, 02 Apr 2023 | CN¥1.2t | CN¥186.0b | CN¥36.6b | 40.5x | 33.7x | 6.6x |
| Tue, 28 Feb 2023 | CN¥1.3t | CN¥179.6b | CN¥38.0b | 43x | 33.5x | 7.1x |
| Thu, 26 Jan 2023 | CN¥1.3t | CN¥179.6b | CN¥38.0b | 44x | 35.2x | 7.4x |
| Sat, 24 Dec 2022 | CN¥1.2t | CN¥175.6b | CN¥37.9b | 37.5x | 31.5x | 6.8x |
| Mon, 21 Nov 2022 | CN¥1.3t | CN¥175.5b | CN¥37.9b | 41.6x | 34.4x | 7.4x |
| Wed, 19 Oct 2022 | CN¥1.2t | CN¥175.6b | CN¥41.1b | 34.5x | 29.7x | 6.9x |
| Fri, 16 Sep 2022 | CN¥1.2t | CN¥174.0b | CN¥40.1b | 32.4x | 29.9x | 6.9x |
| Sun, 14 Aug 2022 | CN¥1.3t | CN¥171.9b | CN¥43.3b | 35.8x | 29.5x | 7.4x |
| Tue, 12 Jul 2022 | CN¥1.3t | CN¥168.1b | CN¥42.4b | 38.2x | 31.5x | 7.9x |
| Thu, 09 Jun 2022 | CN¥1.2t | CN¥168.1b | CN¥42.4b | 37.5x | 28.7x | 7.2x |
Price to Earnings Ratio
28.7x
Current Industry PE
- Investors are optimistic on the Chinese Biotechs industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 106x which is higher than its 3-year average PE of 49.0x.
- The 3-year average PS ratio of 6.4x is lower than the industry's current PS ratio of 7.7x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have declined 42% per year over the last three years,
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | -0.01% | |
| Healthcare | 2.11% | |
| Biotech | 4.01% | |
| Biotech | 4.01% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 688382 InventisBio | CN¥30.80 | 36.4% +CN¥4.8b | 259.0% | PS105.8x | |
| 300204 Staidson (Beijing) BioPharmaceuticals | CN¥26.50 | 53.2% +CN¥4.4b | 331.6% | PS43.2x | |
| 688266 Suzhou Zelgen BiopharmaceuticalsLtd | CN¥108.76 | 16.0% +CN¥4.0b | 99.2% | PS48.6x | |
| 688136 Kexing Biopharm | CN¥53.69 | 33.3% +CN¥2.7b | 171.8% | PE237.8x | |
| 688192 Dizal (Jiangsu) Pharmaceutical | CN¥60.30 | 10.4% +CN¥2.6b | 56.1% | PS63.2x |